Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Collaboration needed for strengthening medical research in Europe

06.02.2008
Public spending on medical research in Europe should be doubled over the next ten years to ensure health and welfare for Europe’s citizens and to nurture a thriving European medical research industry. There should be greater collaboration between European institutions in medical research and improved career paths for medical scientists.

These are some of the main recommendations of the European Medical Research Councils (EMRC) White Paper, ‘Present Status and Future Strategy for Medical Research in Europe’ which was debated at a meeting on 30 January 2008 in Frankfurt (Germany) with the participation of the Heads of Medical Research Councils in Europe, Editors of Medical Journals, Presidents of Medical Learned Societies and Deans of Medical Faculties in Europe.

The audience acclaimed the White paper and made the following recommendations:

Increased funding must be by sustainable growth,

Collaboration on big programmes is essential,

Research areas should be determined by health priorities and not only science topics,

Collaboration on an improvement of peer review of grants is essential - and peer reviewers should be acknowledged and rewarded,

MD/PhD programmes are important and should be of high quality,

the best researchers - like the Nobel Laureates at The Lindau meeting - to participate in teaching,

Novel technologies and research infrastructures are important as well as incentive in terms of decent salaries to attract and retain young researchers

To make the White Paper recommendations come true European and global collaboration is needed.

The White Paper is the result of a comprehensive analysis of the current state of medical research within Europe together with an assessment of the new challenges facing Europe’s citizens, with changing patterns of disease, environmental issues as global warming, and changing demographic factors with an ageing population. The paper was launched at a meeting between Janez Potocnik, EU Commissioner for Science and Research, and Professor Liselotte Højgaard, Chair of the European Medical Research Councils in Brussels on 6 December 2007.

The White Paper key recommendations include:

Implementation of best practice for funding and performing medical research – with distribution of funding in competition based on excellence and evaluated by peer review

Strengthened collaboration and coordination of medical research in Europe through the EMRC and its membership organisations, via the European Commission, the European Research Council and the learned medical societies

Revision of EC directives related to medical research

Implementation of equal opportunities for all researchers

A doubling of public funding of medical research in Europe within the next ten years – to a minimum of 0.25% of gross domestic product (GDP)

Notes for editor
Professor Marja Makarow, Chief Executive European Science Foundation
Professor Liselotte Højgaard, EMRC Chair. Director Clinical Physiology, Nuclear medicine & PET, University of Copenhagen
What is ESF?
The European Science Foundation (ESF) was established in 1974 to create a common European platform for cross-border cooperation in all aspects of scientific research.

With its emphasis on a multidisciplinary and pan-European approach, the Foundation provides the leadership necessary to open new frontiers in European science.

Its activities include providing science policy advice (Science Strategy); stimulating co-operation between researchers and organisations to explore new directions (Science Synergy); and the administration of externally funded programmes (Science Management). These take place in the following areas: Physical and engineering sciences; Medical sciences; Life, earth and environmental sciences; Humanities; Social sciences; Polar; Marine; Space; Radio astronomy frequencies; Nuclear physics.

Headquartered in Strasbourg with offices in Brussels and Ostend the ESF’s membership comprises 77 national funding agencies, research performing agencies and academies from 30 European nations.

The Foundation’s independence allows the ESF to objectively represent the priorities of all these members.

What is EMRC?
The European Medical Research Councils (EMRC) is the European Science Foundation’s membership organisation for all medical research councils in Europe. The mission of the EMRC is to promote innovative medical research and its clinical application towards improved human health. EMRC offers authoritative strategic advice for science policy making, research management, ethics, and better health services. In its activities, EMRC serves as a voice of its Member Organisations and the European scientific community. EMRC disseminates knowledge and promotes the socio-economic value of medical research to the general public and the decision makers.

Press contact:

Sofia Valleley
European Science Foundation
1 Quai Lezay Marnésia – BP 90015
67080 Strasbourg cedex (FR)
+33 388 76 71 49
svalleley@esf.org
Science contact:
EMRC Chair
Professor Liselotte Højgaard, MD DMSc
Director, professor
1Clinical Physiology, Nuclear medicine & PET
Rigshospitalet - University of Copenhagen (DK)
+45 3545 4215 or +45 3545 1792
liselotte.hoejgaard@rh.regionh.dk

Thomas Lau | alfa
Further information:
http://www.esf.org/emrc/whitepaper

More articles from Science Education:

nachricht Studying outdoors is better
06.02.2018 | Technische Universität München

nachricht Classroom in Stuttgart with Li-Fi of Fraunhofer HHI opened
03.11.2017 | Fraunhofer-Institut für Nachrichtentechnik, Heinrich-Hertz-Institut, HHI

All articles from Science Education >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>